Stock Events

Illumina 

$135.41
1
-$4.4-3.15% Wednesday 19:06

Statistics

Day High
140.07
Day Low
133.95
52W High
238
52W Low
89.21
Volume
121,124
Avg. Volume
6,032
Mkt Cap
29.77B
P/E Ratio
0.44
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23AprExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Next
0.02
0.13
0.23
0.34
Expected EPS
0.0616
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0J8Z.LSE. It's not an investment recommendation.

About

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has collaboration agreements with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer; and LetsGetChecked to track COVID-19 variants in California. The company was incorporated in 1998 and is headquartered in San Diego, California.
Show more...
CEO
Mr. Francis A. deSouza
Employees
7800
Country
US
ISIN
US4523271090
WKN
000927079

Listings